Oncolytics Biotech (oncy) Misses Q3 EPS by 25c

Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.

For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.

You May Also Be Interested In

• HP shares slide as tech giant forecasts 2027 PC market slump
• JPMorgan Downgrades Guangdong Marubi Biotechnology Co Ltd (603983:CH) to Underweight
• Rubico to shift from semi-annual to quarterly financial reporting